A detailed history of Parallax Volatility Advisers, L.P. transactions in Bio N Tech Se stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 35,000 shares of BNTX stock, worth $3.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,000
Previous 22,839 53.25%
Holding current value
$3.62 Million
Previous $1.84 Million 126.49%
% of portfolio
0.01%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$78.36 - $124.66 $1.13 Million - $1.79 Million
-14,382 Reduced 62.97%
8,457 $1 Million
Q2 2024

Aug 14, 2024

SELL
$80.36 - $102.87 $1.28 Million - $1.64 Million
-15,990 Reduced 41.18%
22,839 $1.84 Million
Q1 2024

May 15, 2024

BUY
$88.96 - $112.35 $1.13 Million - $1.42 Million
12,683 Added 48.51%
38,829 $3.58 Million
Q4 2023

Feb 14, 2024

SELL
$90.91 - $112.75 $241,093 - $299,013
-2,652 Reduced 9.21%
26,146 $2.76 Million
Q3 2023

Nov 14, 2023

SELL
$98.5 - $125.08 $1.58 Million - $2.01 Million
-16,083 Reduced 35.83%
28,798 $3.13 Million
Q2 2023

Aug 14, 2023

BUY
$102.58 - $129.66 $3.58 Million - $4.53 Million
34,940 Added 351.47%
44,881 $4.84 Million
Q1 2023

May 15, 2023

SELL
$122.57 - $153.67 $4.43 Million - $5.56 Million
-36,175 Reduced 78.44%
9,941 $1.24 Million
Q4 2022

Feb 14, 2023

SELL
$118.43 - $186.05 $115,587 - $181,584
-976 Reduced 2.07%
46,116 $6.93 Million
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $3.69 Million - $5.3 Million
28,923 Added 159.19%
47,092 $6.35 Million
Q2 2022

Aug 15, 2022

SELL
$123.25 - $186.24 $6.39 Million - $9.66 Million
-51,849 Reduced 74.05%
18,169 $2.71 Million
Q1 2022

May 16, 2022

BUY
$126.25 - $231.85 $4.79 Million - $8.8 Million
37,956 Added 118.38%
70,018 $11.9 Million
Q4 2021

Feb 14, 2022

SELL
$216.64 - $362.52 $1.42 Million - $2.38 Million
-6,566 Reduced 17.0%
32,062 $8.27 Million
Q3 2021

Nov 15, 2021

BUY
$205.93 - $447.23 $4.69 Million - $10.2 Million
22,760 Added 143.43%
38,628 $10.5 Million
Q2 2021

Aug 16, 2021

SELL
$113.32 - $241.49 $233,212 - $496,986
-2,058 Reduced 11.48%
15,868 $3.55 Million
Q1 2021

May 14, 2021

BUY
$85.73 - $119.5 $1.27 Million - $1.77 Million
14,775 Added 468.9%
17,926 $1.96 Million
Q4 2020

Feb 16, 2021

BUY
$72.71 - $129.54 $229,109 - $408,180
3,151 New
3,151 $257,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $25.1B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.